Trials / Completed
CompletedNCT02517554
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site | Baseline and follow up survey |
| BEHAVIORAL | Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site | Baseline and follow up surveys |
| BEHAVIORAL | Patient receives written information on how to find genetic services in their area | Baseline and follow up surveys |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2018-03-01
- Completion
- 2019-11-01
- First posted
- 2015-08-07
- Last updated
- 2024-01-19
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02517554. Inclusion in this directory is not an endorsement.